Eli Lilly earnings set to test obesity drug momentum
The obesity drug market has drawn sustained investor attention across the pharmaceutical sector, and Eli Lilly and Company (NYSE: LLY) now faces an upcoming earnings report that will be read as a check on whether the company's…